| Name: | Aripiprazole N4-Oxide |
| Catalogue No. | VE006782 |
| CAS No. | 573691-11-9 |
| Molecular Formula | C23H27Cl2N3O3 |
| Molecular Weight | 464.38 |
| Status | In-stock |
| IUPAC Name | 7-[4-[4-(2,3-Dichlorophenyl)-4-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone |
| Synonyms | Aripiprazole N4-Oxide |
| Description | Aripiprazole N4-Oxide(CAS No: 573691-11-9)or 7-[4-[4-(2,3-Dichlorophenyl)-4-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone. it is used in the treatment of bipolar I disorder, major depressive disorder, and schizophrenia. |
| References | Montastruc, François, et al. “Association of Aripiprazole with the Risk for Psychiatric Hospitalization, Self-Harm, or Suicide.” JAMA Psychiatry, vol. 76, no. 4, Apr. 2019, p. 409, https://doi.org/10.1001/jamapsychiatry.2018.4149. Citrome, Leslie. “A Review of Aripiprazole in the Treatment of Patients with Schizophrenia or Bipolar I Disorder.” Neuropsychiatric Disease and Treatment, vol. 2, no. 4, Dec. 2006, pp. 427–43, www.ncbi.nlm.nih.gov/pmc/articles/PMC2671949/. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
